20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

BKM120 in Action: Advancing Cancer Research with PI3K Inhibition

The PI3K/Akt/mTOR pathway is a central regulator of cell growth, proliferation, survival, and metabolism, and its aberrant activation is a hallmark of many human cancers. Consequently, PI3K inhibitors are a cornerstone of modern oncology drug development. Among these critical compounds, BKM120 (CAS 944396-07-0), also known as Buparlisib or NVP-BKM120, has emerged as a significant tool for researchers seeking to understand and target this pathway.

BKM120 is a potent and selective pan-class I PI3K inhibitor. Its mechanism involves directly targeting the PI3K enzyme, thereby blocking downstream signaling cascades that promote cancer cell survival and proliferation. By inhibiting these processes, BKM120 effectively curbs cell migration and invasion, and crucially, it can induce apoptosis, leading to cancer cell death. This makes it an indispensable reagent for researchers working on novel anticancer agents and combination therapies. If your research demands precise control over PI3K signaling, it is vital to buy PI3K inhibitor BKM120 from a reputable source that guarantees high purity.

The efficacy of BKM120 has been extensively studied in various preclinical cancer models. Studies demonstrate its ability to inhibit tumor growth and sensitize cancer cells to other therapeutic modalities, including chemotherapy and radiotherapy. For scientists aiming to procure Buparlisib for drug discovery, understanding its specific cellular effects is key. As a leading pharmaceutical intermediate manufacturer in China, we provide BKM120 that meets stringent quality standards, ensuring reliable data generation.

Researchers and procurement specialists looking for a dependable CAS 944396-07-0 supplier in China will find our offerings particularly attractive. We are committed to providing high-quality BKM120 at a competitive BKM120 price for research. This allows research institutions and pharmaceutical companies to conduct their vital work without compromising on the quality of their chemical reagents. Partner with us to ensure your cancer research initiatives are supported by top-grade chemical intermediates.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Sourcing High-Purity BKM120: A Procurement Guide for Research Chemicals

Next: The Role of BKM120 in Fibrosis Research: Mechanisms and Sourcing

All Rights Reserved